US45257U1088
US45257U1088
Immunome, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 6.941.000 | 9.041.000 | 23.2% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 231.054.000 | 162.497.000 | 42.2% | |
| Operating Income | -224.113.000 | -153.456.000 | 46.0% |
| Pretax Income | -212.394.000 | -292.963.000 | 27.5% |
| Net Income Common Stockholders | -212.394.000 | -292.963.000 | 27.5% |
| -- | -- | -- | |
| -- | -- | -- |